Researchers Identified New Lung Fibrosis Feedback Circuit
A study revealed how injured cells and fibroblasts sustain lung scarring through a self-amplifying cycle.
Updated on Sept. 21, 2026 in Asthma
Live Poll
Do you believe new discoveries about cellular aging will lead to effective treatments for lung disease?
Scientists have discovered a self-amplifying feedback loop between injured epithelial cells and senescent fibroblasts that sustains pulmonary fibrosis. This cycle involves complex cellular signaling that prevents the lungs from healing.
Why it matters
Understanding this feedback loop is crucial as it maintains lung scarring, a condition that is otherwise difficult to reverse. Disrupting this communication between cell types could lead to new therapeutic strategies for managing fibrosis.
The study observed that sphingosine kinase 1 is induced in injured epithelium, while senescent fibroblasts secrete interleukin-6 to maintain the loop. Blocking sphingosine kinase 1 or S1PR3 receptors reduced bleomycin-induced fibrosis in mice.
The players
Nature Communications
This is a peer-reviewed scientific journal that publishes high-quality research from all areas of the natural sciences.
The details
Epithelial cells produce sphingosine-1-phosphate to activate fibroblast S1PR3 receptors, triggering a signaling pathway that drives cellular senescence. These senescent fibroblasts then secrete interleukin-6, which activates STAT3 in epithelial cells to reactivate sphingosine kinase 1.
Timeline
The research findings were published in Nature Communications on September 21, 2026.
The Big Picture
This discovery shifts the trajectory of pulmonary fibrosis molecular signaling research by isolating the specific interaction between epithelial cells and fibroblasts. It provides a new theoretical framework for how chronic lung scarring is sustained at the cellular level.
While this discovery is currently limited to preclinical models, it identifies potential targets for future drug development that could eventually change how physicians treat lung scarring. Patients should note that this is foundational science and not yet a clinical treatment.
The takeaway
This study highlights that pulmonary fibrosis is driven by a persistent cycle of cellular communication that can be interrupted in laboratory models. Future research will likely focus on whether these molecular pathways can be safely blocked in human subjects.
Further reading
For more information on chronic lung conditions, visit our Asthma section.
Source note: This article includes information reported by Nature.
Live Poll
Do you believe new discoveries about cellular aging will lead to effective treatments for lung disease?
